Release Date: 13/03/14 11:44 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 96.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%